Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.
Team effort: Naomi Petela, Thomas Gligoris and Johanna Scheinost from the Nasmyth lab
Team effort: Naomi Petela, Thomas Gligoris and Johanna Scheinost from the Nasmyth lab

Malarial proteinA new study fills in the gaps in our understanding of a protein complex that traps DNA during cell division until the critical moment just before the daughter cells separate. The researchers behind the work, from Kim Nasmyth's lab in the Department of Biochemistry and the lab of Jan we at the MRC LMB in Cambridge, describe their findings in a recent paper in Science (1). Using new structural information about how the individual components of the cohesin complex fit together, the group has confirmed in living cells what has been suspected to be the case - that the complex adopts a ring structure that holds the two arms of the chromosome together until exactly the right moment in cell division. Researchers can now begin to probe the mechanisms behind cohesin's functions.

Read more (Department of Biochemistry website)

Image: Newly solved crystal structure of part of the cohesin complex

  1. 'Closing the cohesin ring: structure and function of its Smc3-kleisin interface.' Gligoris, TG, Scheinost, JC, Burmann, F, Petela, N, Chan, K-L, Uluocak, P, Beckouet, F, Gruber, S, Nasmyth, K and Lowe, J. Science (2014) Vol. 346 no. 6212 p963-967.

Similar stories

Five ways the pandemic has affected routine medical care

Since the beginning of the pandemic, COVID has infected at least a third of the UK population and is estimated to have factored in the deaths of almost 200,000 people in the UK. But critically, COVID has also had a devastating impact on our healthcare systems. While this was expected, new evidence is beginning to reveal the scope of the issue – in particular the effects for people living with long-term health conditions.

Clinical trials for a malaria vaccine start in Mali and Indonesia

Sanaria Inc. announced that two new Phase 2 trials of its pioneering malaria vaccines have started. The first is in 6- to 10-year-old children living in Bancoumana, Mali, a malarious region of West Africa. The second is in Indonesian soldiers based in Sumatra, Indonesia. The soldiers will be deploying for six to nine months this coming August to an intensely malarious district in eastern Indonesia.

Mechanism of expanding bacteria revealed

A new study published in Nature has identified a potential Achilles heel in the protective layers surrounding Gram-negative bacteria that could aid in the development of next-generation antibiotics.

Discovery of gene involved in chronic pain creates new treatment target

Oxford researchers have discovered a gene that regulates pain sensitisation by amplifying pain signals within the spinal cord, helping them to understand an important mechanism underlying chronic pain in humans and providing a new treatment target.

Oxford's largest ever study into Varicose veins shows need for surgery is linked to genetics

A new international study by Oxford researchers published in Nature Communications establishes for the first time, a critical genetic risk score to predict the likelihood of patients suffering with Varicose veins to require surgery, as well as pointing the way towards potential new therapies.

Biological processes of ageing is key to improving later life health

Improvements in health care, sanitation, and diet over last 100 years have significantly increased life expectancy. However, this increase in how long we can expect to live has not been accompanied by a similar increase in healthy life expectancy, defined as the time spent free of major illness or disease.